Prolonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway of nonhuman primates

Human Gene Therapy

Volumn 20, Issue 3, 2009, Pages 191-200

  Barraza, Román A ^a   Rasmussen, Carol A ^b   Loewen, Nils ^a   Cameron, J Douglas ^a   Gabelt, B'Ann T ^b   Teo, Wu Lin ^a   Kaufman, Paul L ^b   Poeschla, Eric M ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FELINE IMMUNODEFICIENCY VIRUS VECTOR; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS HUMOR OUTFLOW; ARTICLE; CILIARY BODY; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; ENUCLEATION; FLUORESCENCE; GENE EXPRESSION; GLAUCOMA; GONIOSCOPY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTRAOCULAR PRESSURE; IRIS; MONKEY; NONHUMAN; PRIMATE; PROTEIN EXPRESSION; SLIT LAMP; TRABECULAR MESHWORK; TRANSGENE; VIRAL GENE THERAPY;

ANIMALS; AQUEOUS HUMOR; CILIARY BODY; FEMALE; GENE THERAPY; GENETIC VECTORS; GLAUCOMA, OPEN-ANGLE; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; INJECTIONS; IRIS; MACACA FASCICULARIS; MALE; RECOMBINANT PROTEINS; TIME FACTORS; TRABECULAR MESHWORK; TRANSGENES;

FELIDAE; MACACA FASCICULARIS; PRIMATES;

EID: 62549088292     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2008.086     Document Type: Article

References (58)

1. Balaggan, K.S., Binley, K., Esapa, M., Iqball, S., Askham, Z., Kan, O., Tschernutter, M., Bainbridge, J.W., Naylor, S., and Ali, R.R. (2006). Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors. J. Gene Med. 8, 275-285.
2. Bárány, E. (1964). Simultaneous measurements of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion. Invest. Ophthalmol. 3, 135-143.
3. Barraza, R., and Poeschla, E. (2008). Human gene therapy vectors derived from feline lentiviruses. Vet. Immunol. Immunopathol. 123, 23-31.
4. Boland, M.V., and Quigley, H.A. (2007). Risk factors and open-angle glaucoma: Classification and application. J. Glaucoma 16, 406-418.
5. Borras, T., Gabelt, B., Klintworth, K., Peterson, J., and Kaufman, P. (2001). Non-invasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo. J. Gene Med. 3, 437-449.
6. Borras, T., Brandt, C.R., Nickells, R., and Ritch, R. (2002). Gene therapy for glaucoma: Treating a multifaceted, chronic disease. Invest. Ophthalmol. Vis. Sci. 43, 2513-2518.
7. Brown, B.D., Venneri, M.A., Zingale, A., Sergi Sergi, L., and Naldini, L. (2006). Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat. Med. 12, 585-591.
8. Brown, B.D., Cantore, A., Annoni, A., Sergi, L.S., Lombardo, A., Della Valle, P., D'Angelo, A., and Naldini, L. (2007). A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood 110, 4144-4152.
9. +, α/β T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferon. J. Virol. 76, 9398-9406.
10. Diaz-Griffero, F., Vandegraaff, N., Li, Y., McGee-Estrada, K., Stremlau, M., Welikala, S., Si, Z., Engelman, A., and Sodroski, J. (2006). Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1. Virology 351, 404-419.
11. Diaz-Griffero, F., Kar, A., Lee, M., Stremlau, M., Poeschla, E., and Sodroski, J. (2007). Comparative requirements for the restriction of retrovirus infection by TRIM5α and TRIMCyp. Virology 369, 400-410.
12. Ferrer, E. (2006). Trabecular meshwork as a new target for the treatment of glaucoma. Drug News Perspect. 19, 151-158.
13. Gabelt, B.T., Gottanka, J., Lutjen-Drecoll, E., and Kaufman, P.L. (2003). Aqueous humor dynamics and trabecular meshwork and anterior ciliary muscle morphologic changes with age in rhesus monkeys. Invest. Ophthalmol. Vis. Sci. 44, 2118-2125.
14. Gabelt, B.T., Hu, Y., Vittitow, J.L., Rasmussen, C.R., Grosheva, I., Bershadsky, A.D., Geiger, B., Borras, T., and Kaufman, P.L. (2006). Caldesmon transgene expression disrupts focal adhesions in HTM cells and increases outflow facility in organcultured human and monkey anterior segments. Exp. Eye Res. 82, 935-944.
15. Grant, W.M. (1963). Experimental aqueous perfusion in enucleated human eyes. Arch. Ophthalmol. 69, 783-801.
16. Grierson, I., and Howes, R.C. (1987). Age-related depletion of the cell population in the human trabecular meshwork. Eye 1, 204-210.
17. Hattenhauer, M.G., Johnson, D.H., Ing, H.H., Herman, D.C., Hodge, D.O., Yawn, B.P., Butterfield, L.C., and Gray, D.T. (1998). The probability of blindness from open-angle glaucoma. Ophthalmology 105, 2099-2104.
18. Hatziioannou, T., Cowan, S., Goff, S.P., Bieniasz, P.D., and Towers, G.J. (2003). Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J. 22, 385-394.
19. Honjo, M., Tanihara, H., Inatani, M., Kido, N., Sawamura, T., Yue, B.Y., Narumiya, S., and Honda, Y. (2001). Effects of Rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest. Ophthalmol. Vis. Sci. 42, 137-144.
20. Kaufman, P.L., and Davis, G.E. (1980). "Minified" Goldmann applanating prism for tonometry in monkeys and humans. Arch. Ophthalmol. 98, 542-546.
21. Kee, C., Sohn, S., and Hwang, J.M. (2001). Stromelysin gene transfer into cultured human trabecular cells and rat trabecular meshwork in vivo. Invest. Ophthalmol. Vis. Sci. 42, 2856-2860.
22. Khare, P., Loewen, N., Teo, W., Barraza, R.A., Saenz, D.T., Johnson, D.H., and Poeschla, E.M. (2007). Durable, safe, multigene lentiviral vector expression in feline trabecular meshwork. Mol. Ther. 16, 97-106.
23. Lin, T.Y., and Emerman, M. (2006). Cyclophilin A interacts with diverse lentiviral capsids. Retrovirology 3, 70.
24. Liu, X., Brandt, C.R., Rasmussen, C.A., and Kaufman, P.L. (2007). Ocular drug delivery: Molecules, cells, and genes. Can. J. Ophthalmol. 42, 447-454.
25. Loewen, N., and Poeschla, E.M. (2005). Lentiviral vectors. Adv. Biochem. Eng. Biotechnol. 99, 169-191.
26. Loewen, N., Fautsch, M., Peretz, M., Bahler, C., Cameron, J.D., Johnson, D.H., and Poeschla, E.M. (2001). Genetic modification of human trabecular meshwork with lentiviral vectors. Hum. Gene Ther. 12, 2109-2119.
27. Loewen, N., Bahler, C., Teo, W., Whitwam, T., Peretz, M., Xu, R., Fautsch, M., Johnson, D.H., and Poeschla, E.M. (2002). Preservation of aqueous outflow facility after second-generation FIV vector-mediated expression of marker genes in anterior segments of human eyes. Invest. Ophthalmol. Vis. Sci. 43, 3686-3690.
28. Loewen, N., Barraza, R., Whitwam, T., Saenz, D.T., Kemler, I., and Poeschla, E. (2003a). FIV vectors.Methods Mol. Biol. 229, 251-271.
29. Loewen, N., Leske, D., Chen, Y., Teo, W., Saenz, D.T., Peretz, M., Holmes, J., and Poeschla, E.M. (2003b). Comparison of wildtype and class I integrase mutant-FIV vectors in retina demonstrates sustained expression of integrated transgenes in retinal pigment epithelium. J. Gene Med. 5, 1009-1017.
30. Loewen, N., Fautsch, M.P., Teo, W.L., Bahler, C.K., Johnson, D.H., and Poeschla, E.M. (2004a). Long-term, targeted genetic modification of the aqueous humor outflow tract coupled with noninvasive imaging of gene expression in vivo. Invest. Ophthalmol. Vis. Sci. 45, 3091-3098.
31. Loewen, N., Leske, D.A., Cameron, J.D., Chen, Y., Whitwam, T., Simari, R.D., Teo, W.L., Fautsch, M.P., Poeschla, E.M., and Holmes, J.M. (2004b). Long-term retinal transgene expression with FIV versus adenoviral vectors. Mol. Vis. 10, 272-280.
32. Martin, K.R., and Quigley, H.A. (2004). Gene therapy for optic nerve disease. Eye 18, 1049-1055.
33. Mitrophanous, K., Yoon, S., Rohll, J., Patil, D., Wilkes, F., Kim, V., Kingsman, S., Kingsman, A., and Mazarakis, N. (1999). Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther. 6, 1808-1818.
34. Naldini, L., Bloemer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M., and Trono, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
35. Olsen, J.C. (1998). Gene transfer vectors derived from equine infectious anemia virus. Gene Ther. 5, 1481-1487.
36. Poeschla, E., Wong-Staal, F., and Looney, D. (1998). Efficient transduction of nondividing cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4, 354-357.
37. Quigley, H.A., and Broman, A.T. (2006). The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90, 262-267.
38. Rao, P.V., Deng, P.F., Kumar, J., and Epstein, D.L. (2001). Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest. Ophthalmol. Vis. Sci. 42, 1029-1037.
39. Rasmussen, C.A., and Kaufman, P.L. (2005). Primate glaucoma models. J. Glaucoma 14, 311-314.
40. Rezaie, T., Child, A., Hitchings, R., Brice, G., Miller, L., Coca-Prados, M., Heon, E., Krupin, T., Ritch, R., Kreutzer, D., Crick, R.P., and Sarfarazi, M. (2002). Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295, 1077-1079.
41. Rohen, J.W. (1983). Why is intraocular pressure elevated in chronic simple glaucoma? Anatomical considerations. Ophthalmology 90, 758-765.
42. Saenz, D.T., and Poeschla, E.M. (2004). FIV: From lentivirus to lentivector. J. Gene Med. 6(Suppl. 1), S95-S104.
43. Saenz, D.T., Teo, W., Olsen, J.C., and Poeschla, E. (2005). Restriction of feline immunodeficiency virus by Ref1, LV1 and primate TRIM5α proteins. J. Virol. 79, 15175-15188.
44. Saenz, D.T., Barraza, R., Loewen, N., Teo, W., and Poeschla, E. (2006). Production and use of feline immunodeficiency virus (FIV)-based lentiviral vectors. In GeneTransfer: A Cold Spring Harbor Laboratory Manual. J. Rossi and T. Friedman, eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 57-74.
45. Sagara, T., Gaton, D.D., Lindsey, J.D., Gabelt, B.T., Kaufman, P.L., and Weinreb, R.N. (1999). Topical prostaglandin F2α treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway. Arch. Ophthalmol. 117, 794-801.
46. Schwartz, G. (2006). Adherence and persistence in glaucoma. In Glaucoma. F. Grehn and R. Stamper, eds. (Springer-Verlag, Berlin) pp. 91-105.
47. 2α-isopropyl ester to latanoprost: A review of the development of xalatan. The Proctor Lecture. Invest. Ophthalmol. Vis. Sci. 42, 1134-1145.
48. Stone, E.M., Fingert, J.H., Alward, W.L.M., Nguyen, T.D., Polansky, J.R., Sunden, S.L.F., Nishimura, D., Clark, A.F., Nystuen, A., Nichols, B.E., Mackey, D.A., Ritch, R., Kalenak, J.W., Craven, E.R., and Sheffield, V.C. (1997). Identification of a gene that causes primary open angle glaucoma. Science 275, 668-670.
49. Stremlau, M., Owens, C.M., Perron, M.J., Kiessling, M., Autissier, P., and Sodroski, J. (2004). The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853.
50. Tian, B., and Kaufman, P.L. (2005). Effects of the Rho kinase inhibitor Y-27632 and the phosphatase inhibitor calyculin A on outflow facility in monkeys. Exp. Eye Res. 80, 215-225.
51. Toris, C.B., Zhan, G.L., Feilmeier, M.R., Camras, C.B., and McLaughlin, M.A. (2006). Effects of a prostaglandin DP receptor agonist, AL-6598, on aqueous humor dynamics in a nonhuman primate model of glaucoma. J. Ocul. Pharmacol. Ther. 22, 86-92.
52. Virgen, C.A., Kratovac, Z., Bieniasz, P.D., and Hatziioannou, T. (2008). Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc. Natl. Acad. Sci. U.S.A. 105, 3563-3568.
53. Wang, R.F., Gagliuso, D.J., Mittag, T.W., and Podos, S.M. (2007). Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes. Invest. Ophthalmol. Vis. Sci. 48, 4143-4147.
54. Wang, W.H., McNatt, L.G., Pang, I.H., Millar, J.C., Hellberg, P.E., Hellberg, M.H., Steely, H.T., Rubin, J.S., Fingert, J.H., Sheffield, V.C., Stone, E.M., and Clark, A.F. (2008). Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressure. J. Clin. Invest. 118, 1056-1064.
55. Wang, Y.L., Toris, C.B., Zhan, G., and Yablonski, M.E. (1999). Effects of topical epinephrine on aqueous humor dynamics in the cat. Exp. Eye Res. 68, 439-445.
56. Weinreb, R.N., Toris, C.B., Gabelt, B.T., Lindsey, J.D., and Kaufman, P.L. (2002). Effects of prostaglandins on the aqueous humor outflow pathways. Surv. Ophthalmol. 47(Suppl. 1), S53-S64.
57. Wilson, S.J., Webb, B.L., Ylinen, L.M., Verschoor, E., Heeney, J.L., and Towers, G.J. (2008). Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc. Natl. Acad. Sci. U.S.A. 105, 3557-3562.
58. Zhan, G.L., Miranda, O.C., and Bito, L.Z. (1992). Steroid glaucoma: Corticosteroid-induced ocular hypertension in cats. Exp. Eye Res. 54, 211-218.